Home
Home

Dyax

News

Cubist Pharma says reviewers found more deaths in patients taking its drug; Dyax stock skids
Yahoo/AP
»

News

FDA Approves Two New Drugs
TheStreet.com
»

News

Biotech Calendar: Key Dates for December
TheStreet.com
»

News

DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
BusinessWire
»

News

Dyax says Sanofi-Aventis recently licensed eye drug and cancer drug from Dyax collaborators
Yahoo/AP
»

News

FDA Calendar Updates: King Pharma, Pain Therapeutics
Seeking Alpha
»

News

Dyax's response for more information on DX-88 gets FDA acceptance, decision expected by Dec.
Yahoo/AP
»

News

FDA and Clinical Trial Updates: Osiris Sees Flaw in Crohn's Disease Trial
Seeking Alpha
»

News

Dyax: A Cinderella Story Ends in a Fall
Motley Fool
»

News

Dyax says FDA wants risk strategy and other additional data on DX-88, but no new trials
Yahoo/AP
»